UnitedHealth Group Incorporated (UNH)
UnitedHealth aims to reassure investors as profits plunge, DOJ investigates its Medicare business
UnitedHealth's second-quarter earnings comes two and a half months since Chairman and CEO Stephen Hemsley retook the role of chief executive. Investors will be watching for how Hemsley plans to stabilize the company's embattled Medicare Advantage program and Optum Health physician practices.
UnitedHealth: Turning Into A Falling Knife
UnitedHealth Group's stock has plunged about 45% YTD, reflecting a series of structural headwinds. Wall Street sentiment is overwhelmingly negative, with analysts forecasting a 30%+ YoY EPS drop over the next three quarters and universally revising Q2 earnings estimates downward. Rising medical utilization and a surge in elective care have driven up costs, eroding profitability and signaling that the pandemic-era tailwinds are firmly in the past.
Wall Street sets UnitedHealth stock price ahead of Q2 earnings report
After a tumultuous first half of the year, American insurance giant UnitedHealth (NYSE: UNH) is back in focus ahead of its Q2 earnings report, scheduled for July 29.
CVS or UnitedHealth: Which Stock Is a Better Buy Ahead of Q2 Earnings?
CVS shows resilience with stable insurance margins and capital discipline, while UNH faces cost headwinds and a sharp earnings cut.
UnitedHealthcare Pressure Builds: Trouble Ahead for UNH's Q2 Earnings?
UNH braces for a steep Q2 profit drop as soaring medical costs and DOJ scrutiny shake investor confidence.
UnitedHealth Group confirms DOJ investigation over Medicare billing
UnitedHealth Group says it is cooperating with federal criminal and civil investigations involving its market-leading Medicare business.
UnitedHealth Group (UNH) Stock Sinks As Market Gains: Here's Why
In the closing of the recent trading day, UnitedHealth Group (UNH) stood at $278.58, denoting a -4.76% move from the preceding trading day.
UnitedHeath shares fall after health-care giant admits DOJ fraud probe into Medicare business
Company shares have tumbled since December, when UnitedHealthcare CEO Brian Thompson was fatally shot in midtown Manhattan.
UnitedHealth on Thin Ice Before Q2 Earnings: Should Investors Exit?
UNH braces for a 27% earnings drop in Q2 as soaring medical costs, margin pressure and investor jitters weigh on performance.
Morning Headlines Defy Expectations, but Pre-Markets Sell
Only the tech-heavy (AI-trade-heavy) Nasdaq is in the green at this hour.
UnitedHealth confirms DOJ criminal probe two months after calling a report of one ‘irresponsible'
UnitedHealth Group's stock fell Thursday after the company confirmed government criminal and civil investigations into its Medicare practices but stressed that it doesn't expect to be charged with any wrongdoing.
Wall Street's Insights Into Key Metrics Ahead of UnitedHealth (UNH) Q2 Earnings
Evaluate the expected performance of UnitedHealth (UNH) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
